Noble gas neuroprotection: Xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms
File(s)1-s2.0-S0007091219305720-main.pdf (836.71 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Background
Noble gases may provide novel treatments for neurological injuries such as ischaemic and traumatic brain injury. Few studies have evaluated the complete series of noble gases under identical conditions in the same model.
Methods
We used an in vitro model of hypoxia–ischaemia to evaluate the neuroprotective properties of the series of noble gases, helium, neon, argon, krypton, and xenon. Organotypic hippocampal brain slices from mice were subjected to oxygen-glucose deprivation, and injury was quantified using propidium iodide fluorescence.
Results
Both xenon and argon were equally effective neuroprotectants, with 0.5 atm of xenon or argon reducing injury by 96% (P<0.0001), whereas helium, neon, and krypton were devoid of any protective effect. Neuroprotection by xenon, but not argon, was reversed by elevated glycine.
Conclusions
Xenon and argon are equally effective as neuroprotectants against hypoxia–ischaemia in vitro, with both gases preventing injury development. Although xenon's neuroprotective effect may be mediated by inhibition of the N-methyl-d-aspartate receptor at the glycine site, argon acts via a different mechanism. These findings may have important implications for their clinical use as neuroprotectants.
Noble gases may provide novel treatments for neurological injuries such as ischaemic and traumatic brain injury. Few studies have evaluated the complete series of noble gases under identical conditions in the same model.
Methods
We used an in vitro model of hypoxia–ischaemia to evaluate the neuroprotective properties of the series of noble gases, helium, neon, argon, krypton, and xenon. Organotypic hippocampal brain slices from mice were subjected to oxygen-glucose deprivation, and injury was quantified using propidium iodide fluorescence.
Results
Both xenon and argon were equally effective neuroprotectants, with 0.5 atm of xenon or argon reducing injury by 96% (P<0.0001), whereas helium, neon, and krypton were devoid of any protective effect. Neuroprotection by xenon, but not argon, was reversed by elevated glycine.
Conclusions
Xenon and argon are equally effective as neuroprotectants against hypoxia–ischaemia in vitro, with both gases preventing injury development. Although xenon's neuroprotective effect may be mediated by inhibition of the N-methyl-d-aspartate receptor at the glycine site, argon acts via a different mechanism. These findings may have important implications for their clinical use as neuroprotectants.
Date Issued
2019-11-01
Date Acceptance
2019-07-19
Citation
British Journal of Anaesthesia, 2019, 123 (5), pp.601-609
ISSN
1471-6771
Publisher
Elsevier
Start Page
601
End Page
609
Journal / Book Title
British Journal of Anaesthesia
Volume
123
Issue
5
Copyright Statement
©2019 The Authors. Published by Elsevier Ltd on behalf of British Journal of Anaesthesia. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
License URL
Sponsor
British Journal of Anaesthesia
Westminster Medical School Research Trust
Royal Centre for Defence Medicine
British Journal of Anaesthesia
European Society of Anaesthesiology
Ashford and St Peter's Hospitals NHS Foundation Trust
Medical Research Council (MRC)
Medical Research Council (MRC)
The Gas Safety Trust
Royal Centre for Defence Medicine
Grant Number
2009(2) NIAA Grants Round
JRC 1-/11 PHD 001
20120229-DMSRASG/Xenon
BJA/RCoA Grants NIAA Round 2
N/A
WSSA_P51346
MC_PC_13064
MR/N027736/1
WSSA_P64107
1012/4
Subjects
acute brain injury
carbon monoxide poisoning
hypoxic–ischaemic encephalopathy
neuroprotection
noble gases
out-of-hospital cardiac arrest
stroke
Anesthesiology
1103 Clinical Sciences
Publication Status
Published
Date Publish Online
2019-08-27